Z-0825-2021 Class II Ongoing
FDA device recall Z-0825-2021 was initiated by Fresenius Medical Care Holdings, Inc. on Nov 7, 2020 and is designated Class II. Reason for recall: The sodium and/or calcium levels in these concentrates were below the manufacturing specifications. The recall status is ongoing. Affected quantity: 592 drums.
Recall details
- Product Type
- Devices
- Report Date
- Jan 20, 2021
- Initiation Date
- Nov 7, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 592 drums
Product description
NaturaLyte Liquid Acid concentrate drums, Model Number 13-2251-0 - Product Usage: used in conjunction with Fresenius Renal Technologies Sodium Bicarbonate Concentrate in a compatible 45X dilution three-stream artificial kidney (hemodialysis) machine.
Reason for recall
The sodium and/or calcium levels in these concentrates were below the manufacturing specifications.
Distribution pattern
US Nationwide distribution.
Code information
Lot Numbers: 20LXAC070 20LXAC103 20NXAC021 20LXAC100 20LXAC026 20LXAC027 20LXAC028 20LXAC029 20LXAC065 20LXAC067 20LXAC071 20NXAC001 20NXAC019 20NXAC020 20NXAC029 Additional affected lots as of 3/17/21: 20LXAC103 20LXAC082 20LXAC025 20LXAC081 20LXAC083
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-0825-2021
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026